Modeling kinetic data from in vitro drug metabolism enzyme experiments

Drug Metabolism Reviews

Volumn 36, Issue 2, 2004, Pages 231-242

  Tracy, Timothy S ^a   Hummel, Matthew A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Atypical kinetic; Drug metabolism enzyme; Kinetic modeling; Typical kinetic

Indexed keywords

ATYPICAL KINETICS; BIPHASIC KINETICS; CONFERENCE PAPER; DECISION MAKING; DRUG CLEARANCE; DRUG METABOLISM; DRUG STABILITY; ENZYME KINETICS; ENZYME METABOLISM; HETEROTROPIC COOPERATIVITY; IN VITRO STUDY; IN VIVO STUDY; KINETIC MODELING; MICHAELIS MENTEN KINETICS; MODEL; SIGMOIDAL KINETICS; SUBSTRATE INHIBITION KINETICS; TYPICAL KINETICS;

ALGORITHMS; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; KINETICS; MODELS, MOLECULAR; PHARMACEUTICAL PREPARATIONS;

EID: 3042608648     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-120033999     Document Type: Conference Paper

References (17)

1. Cameron, M. D., Allen, K. E., Wen, B., Campbell, A. P., Nelson, S. D. (2003). NMR Evidence for Simultaneous Binding of Midazolam with Alpha-Naphthoflavone or Testosterone with the Active Site of CYP3A4. Society of Toxicology Annual Meeting, 335.
2. Galetin, A., Clarke, S. E., Houston, J. B. (2002). Quinidine and haloperidol as modifiers of CYP3A4 activity: multisite kinetic model approach. Drug Metab. Dispos. 30 (12):1512-1522.
3. Galetin, A., Clarke, S. E., Houston, J. B. (2003). Multisite kinetic analysis of interactions between prototypical CYP3A4 subgroup substrates: midazolam, testosterone, and nifedipine. Drug Metab. Dispos. 31(9):1108-1116.
4. Houston, J. B. (1994). Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem. Pharmacol. 47(9):1469-1479.
5. Houston, J. B., Carlile, D. J. (1997). Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices. Drug Metab. Rev. 29(4):891-922.
6. Hummel, M. A., Gannett, P. M., Tracy, T. S. (2003) Evaluation of Proton to Heme Distances of Flurbiprofen and Dapsone Within the Active-Site of CYP2C9. 12th North American ISSX Meeting, 201.
7. Hutzler, J. M., Tracy, T. S. (2002). Atypical kinetic profiles in drug metabolism reactions. Drug Metab. Dispos. 30(4):355-362.
8. Hutzler, J. M., Hauer, M. J., Tracy, T. S. (2001). Dapsone activation of CYP2C9-mediated metabolism: evidence for activation of multiple substrates and a two-site model. Drug Metab. Dispos. 29(7):1029-1034.
9. Hutzler, J. M., Wienkers, L. C., Wahlstrom, J. L., Carlson, T. J., Tracy, T. S. (2003). Activation of cytochrome P450 2C9-mediated metabolism: mechanistic evidence in support of kinetic observations. Arch. Biochem. Biophys. 410:16-24.
10. Kenworthy, K. E., Clarke, S. E., Andrews, J., Houston, J. B. (2001). Multisite kinetic models for CYP3A4: simultaneous activation and inhibition of diazepam and testosterone metabolism. Drug Metab. Dispos. 29(12):1644-1651.
11. Korzekwa, K. R., Krishnamachary, N., Shou, M., Ogai, A., Parise, R. A., Rettie, A. E., Gonzalez, F. J., Tracy, T. S. (1998). Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry 37(12):4137-4147.
12. Lin, Y., Lu, P., Tang, C., Mei, Q., Sandig, G., Rodrigues, A. D., Rushmore, T. H., Shou, M. (2001). Substrate inhibition kinetics for cytochrome P450-catalyzed reactions. Drug Metab. Dispos. 29(4 Pt. 1):368-374.
13. Loida, P. J., Sligar, S. G. (1993). Molecular recognition in cytochrome P-450: mechanism for the control of uncoupling reactions. Biochemistry 32(43):11530-11538.
14. Obach, R. S. (1997). Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Drug Metab. Dispos. 25(12):1359-1369.
15. Shou, M., Mei, Q., Ettore, M. W. Jr., Dai, R., Baillie, T. A., Rushmore, T. H. (1999). Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives. Biochem. J. 340(Pt. 3):845-853.
16. Shou, M., Lin, Y., Lu, P., Tang, C., Mei, Q., Cui, D., Tang, W., Ngui, J. S., Lin, C. C., Singh, R., Wong, B. K., Yergey, J. A., Lin, J. H., Pearson, P. G., Baillie, T. A., Rodrigues, A. D., Rushmore, T. H. (2001a). Enzyme kinetics of cytochrome P450-mediated reactions. Curr. Drug Metab. 2(1):17-36.
17. Shou, M., Dai, R., Cui, D., Korzekwa, K. R., Baillie, T. A., Rushmore, T. H. (2001b). A kinetic model for the metabolic interaction of two substrates at the active site of cytochrome P450 3A4. J. Biol. Chem. 276(3):2256-2262.